Lipella Pharmaceuticals to Present at 2024 Spartan Capital Investor Conference
Lipella Pharmaceuticals (Nasdaq: LIPO), a clinical-stage biotechnology company, has announced its participation in the 2024 Spartan Capital Investor Conference. CEO Jonathan Kaufman, PhD, will deliver a presentation on November 4th, 2024, at 9:25 am EST at the Pierre Hotel in New York. The company, which focuses on addressing serious diseases with significant unmet needs, will also offer one-on-one meetings with registered conference investors.
Lipella Pharmaceuticals (Nasdaq: LIPO), un'azienda biotecnologica in fase clinica, ha annunciato la sua partecipazione alla Conferenza degli Investitori Spartan Capital 2024. Il CEO Jonathan Kaufman, PhD, effettuerà una presentazione il 4 novembre 2024, alle 9:25 EST, presso l'Hotel Pierre a New York. L'azienda, che si concentra sulla cura di malattie gravi con esigenze insoddisfatte significative, offrirà anche incontri individuali con gli investitori registrati alla conferenza.
Lipella Pharmaceuticals (Nasdaq: LIPO), una empresa biotecnológica en etapa clínica, ha anunciado su participación en la Conferencia de Inversores Spartan Capital 2024. El CEO Jonathan Kaufman, PhD, realizará una presentación el 4 de noviembre de 2024, a las 9:25 am EST en el Hotel Pierre de Nueva York. La empresa, que se centra en abordar enfermedades graves con necesidades no satisfechas significativas, también ofrecerá reuniones individuales con los inversores registrados en la conferencia.
리펠라 제약 (Nasdaq: LIPO), 임상 단계의 바이오텍 기업이 2024 스파르탄 캐피탈 투자자 컨퍼런스에 참여한다고 발표했습니다. CEO 조나단 카우프만 박사가 2024년 11월 4일 오전 9시 25분 EST에 뉴욕의 피에르 호텔에서 발표를 진행할 예정입니다. 심각한 질병과 중대한 unmet needs를 해결하는 데 초점을 맞춘 이 회사는 등록된 투자자들과의 일대일 회의도 제공합니다.
Lipella Pharmaceuticals (Nasdaq: LIPO), une société biopharmaceutique en phase clinique, a annoncé sa participation à la Conférence des Investisseurs Spartan Capital 2024. Le PDG Jonathan Kaufman, PhD, fera une présentation le 4 novembre 2024 à 9h25 EST à l'Hôtel Pierre à New York. L'entreprise, qui se concentre sur le traitement des maladies graves ayant des besoins non satisfaits importants, proposera également des rencontres individuelles avec les investisseurs inscrits à la conférence.
Lipella Pharmaceuticals (Nasdaq: LIPO), ein biopharmazeutisches Unternehmen in der klinischen Phase, hat seine Teilnahme an der 2024 Spartan Capital Investor Conference bekannt gegeben. CEO Jonathan Kaufman, PhD, wird am 4. November 2024 um 9:25 Uhr EST im Pierre Hotel in New York eine Präsentation halten. Das Unternehmen, das sich auf die Behandlung schwerer Krankheiten mit erheblichen ungedeckten Bedürfnissen konzentriert, bietet auch Einzelgespräche mit registrierten Investoren der Konferenz an.
- None.
- None.
PITTSBURGH, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals, Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on addressing serious diseases with significant unmet needs, today announced that CEO Jonathan Kaufman, PhD will be presenting at the 2024 Spartan Capital Investor Conference that is being held on November 4, 2024, at the Pierre Hotel in New York.
Event: Lipella Presentation - 2024 Spartan Capital Investor Conference
Date: Monday, November 4th, 2024
Time: 9:25 am EST
Jonathan Kaufman will be available for one-on-one meetings with registered investors of the conference.
About Lipella Pharmaceuticals
Lipella is a clinical-stage biotechnology company focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. Additionally, Lipella maintains a therapeutic focus on diseases with significant, unaddressed morbidity and mortality where no approved drug therapy currently exists. Lipella completed its initial public offering in December 2022. For more information, please visit www.lipella.com or LinkedIn
CONTACT
Jeff Ramson
PCG Advisory
jramson@pcgadvisory.com
646-863-6893
FAQ
When is Lipella Pharmaceuticals (LIPO) presenting at the 2024 Spartan Capital Investor Conference?
Where will the 2024 Spartan Capital Investor Conference featuring Lipella (LIPO) be held?
Will Lipella Pharmaceuticals (LIPO) offer individual meetings at the Spartan Capital Conference?
What type of company is Lipella Pharmaceuticals (LIPO)?
